Stock Events

Stock Events

Celldex Therapeutics (CLDX) Q2 2026 Earnings

7MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-1.18

-1.04

-0.9

-0.75

Details

Expected EPS

-1.150154

Actual EPS

-1.18

Surprise EPS

-0.03

Surprise Percent

+2.59%

Description

Celldex Therapeutics (CLDX) has reported earnings of -1.18 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.